Research Studies

Study Title

CReATe Consortium: TRIAL READY Study

Enrollment Status

Current

Principal Investigators

Michael Benatar, MD, PhD

Study Type

Observational

Goals

Validate leading biomarker candidates for potential prognostic, disease progression, and pharmacodynamic purposes

Enrolling

Controls (recruiting), ALS patients (no longer recruiting)

Eligibility

Click to Expand

Controls:

  • Age 18+
  • Never diagnosed with (and not at a particular risk of developing) ALS or an ALS related disorder
  • Able and willing to comply with study procedures

Affected (not currently recruiting):

  • Age 18+
  • Clinical diagnosis of ALS or an ALS related disorder
  • Willing to undergo C9ORF72 screening and to learn the results
  • Able and willing to comply with other study procedures

Study Involvement

Click to Expand

Controls: 5 half-day study visits at UMiami (or another study site) over a 1-year period

  • Family and medical history review
  • Blood, urine, and (optional) CSF collection
  • Breathing test
  • Neuropsychological assessment
  • Questionnaires/surveys
  • Neurological exam (one-time)

Affected: (No longer recruiting)

Primary Funding Source

NIH

Related Publications

Click to Expand

No items found

Related Presentations & Lectures

Click to Expand

No items found